Amgen Rebuilt R&D Platform To Focus On Speed And Access
Genetics, AI And Other Tools Assembled Over Past Decade
Feb 12 2022
•
By
Mandy Jackson
Amgen's first big investment in genomics was the acquisition of decode in 2012 • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Strategy
More from Business
